My first first-author paper is out on JITC!

Thank you to everyone involved, especially the patients that provided us their samples for this study, & Mike for the opportunity.

@bailey-bye.bsky.social
@mruckert.bsky.social
@VansaunLab.bsky.social

bsky.app/profile/sitc...

#PDAC #scisky #science

New Journal for ImmunoTherapy of Cancer (JITC) article: Depletion of tumor-derived CXCL5 improves T cell infiltration and anti-PD-1 therapy response in an obese model of pancreatic cancer bit.ly/4bZUKWM

@bailey-bye.bsky.social @mruckert.bsky.social

#JITC #MedSky #OncSky #pancreatic #therapy